Details of the Drug

General Information of Drug (ID: DM5LSN1)

Drug Name
EDS-EP
Indication
Disease Entry ICD 11 Status REF
Ataxia-telangiectasia 4A01.31 Phase 3 [1]
Cross-matching ID
TTD ID
D0NE8F

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)